Not intended for medical, therapeutic, diagnostic or clinical applications
Injections are the most powerful placebo available
titer blood tests near San Leandro at CityHealth.
BPC-157 accelerates repair that is already underway
Both compounds share the same regulatory timeline: moved to Category 2 in 2023, removed from Category 2 in April 2026, and scheduled for PCAC review on July 23, 2026
In addition, IHC for VEGF-A (Proteintech, Chicago, IL, USA) and CD34 (Proteintech, Chicago, IL, USA) were performed using the automated IHC system (Hoffman La-Roche Ltd., Basel, Switzerland)